1)Gilligan CJ, Lawton GP, Tang LH, et al:Gastric carcinoid tumors:the biology and therapy of an enigmatic and controversial lesion. Am J Gastroenterol 90:338-352, 1995
2)Konishi T, Watanabe T, Kishimoto J, et al:Prognosis and risk factors of metastasis in colorectal carcinoids:results of a nationwide registry over 15 years. Gut 56:863-868, 2007
3)Kandulski A, Fry LC, Malfertheiner P:Detection of jejunal carcinoid in a patient with obscure-overt gastrointestinal bleeding by double-balloon enteroscopy. Clin Gastroenterol Hepatol 6:A26, 2008
4)Soga J:Carcinoid tumors:a statistical analysis of a Japanese series of 3, 126 reported and 1, 180 autopsy cases. Acta Medica et Biologica 42:87-102, 1994
5)Ishii N, Horiki N, Itoh T, et al:Endoscopic submucosal dissection and preoperative assessment with endoscopic ultrasonography for the treatment of rectal carcinoid tumors. Surg Endosc 24:1413-1419, 2010
6)Fujimoto Y, Oya M, Kuroyanagi H, et al:Lymph-node metastases in rectal carcinoids. Langenbecks Arch Surg 395:139-142, 2010
7)Modlin IM, Oberg K, Chung DC, et al:Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol 9:61-72, 2008
8)Semelka RC, Custodio CM, Balci NC, et al:Neuroendocrine tumors of the pancreas:spectrum of appearances on MRI. J Magn Reson Imaging 11:141-148, 2000
9)Dromain C, de Baere T, Lumbroso J, et al:Detection of liver metastases from endocrine tumors:a prospective comparison of somatostatin receptor scintigraphy, computed tomography, and magnetic resonance imaging. J Clin Oncol 23:70-78, 2005
10)Puli SR, Kalva N, Bechtold ML, et al:Diagnostic accuracy of endoscopic ultrasound in pancreatic neuroendocrine tumors:a systematic review and meta analysis. World J Gastroenterol 19:3678-3684, 2013
11)Khashab MA, Yong E, Lennon AM, et al:EUS is still superior to multidetector computerized tomography for detection of pancreatic neuroendocrine tumors. Gastrointest Endosc 73:691-696, 2011
12)肱岡 範,長谷川俊之,山雄健次:PNETの穿刺吸引細胞診(FNA):どの方法がベストで,そして何がわかるのか(AYUMI膵内分泌腫瘍(PNET)).医学のあゆみ241:138-143,2012
13)肱岡 範,近藤真也,丹羽康正,他:鑑別診断と局在診断.今村正之(総監):膵・消化管神経内分泌腫瘍(NET)診断・治療実践マニュアル.総合医学社,2011,editor 2011
14)肱岡 範,堤 英治,原 和生:膵NENに対するEUSとEUS-FNAの診断の実際:生検診断の有用性と問題点.胆と膵35:627-634,2014
15)Imamura M, Takahashi K, Adachi H, et al:Usefulness of selective arterial secretin injection test for localization of gastrinoma in the Zollinger-Ellison syndrome. Ann Surg 205:230-239, 1987
16)Wada M, Komoto I, Doi R, et al:Intravenous calcium injection test is a novel complementary procedure in differential diagnosis for gastrinoma. World J Surg 26:1291-1296, 2002
17)Rustagi T, Farrell JJ:Endoscopic Diagnosis and Treatment of Pancreatic Neuroendocrine Tumors. J Clin Gastroenterol 48:837-844, 2014
18)McCall CM, Shi C, Klein AP, et al:Serotonin expression in pancreatic neuroendocrine tumors correlates with a trabecular histologic pattern and large duct involvement. Human pathology 43:1169-1176, 2012
19)小倉 健,有坂好史,瀧井道明,他:主膵管狭窄を合併した微小な非機能性膵内分泌腫瘍の1例.膵臓27:701-709,2012
20)d'Assignies G, Couvelard A, Bahrami S, et al:Pancreatic endocrine tumors:tumor blood flow assessed with perfusion CT reflects angiogenesis and correlates with prognostic factors1. Radiology 250:407-416, 2009
21)近藤真也,肱岡 範,丹羽康正,他:生検による鑑別診断.今村正之(総監):膵・消化管神経内分泌腫瘍(NET)診断・治療実践マニュアル.総合医学社,editor 2011
22)Ginès A, Vazquez-Sequeiros E, Soria MT, et al:Usefulness of EUS-guided fine needle aspiration(EUS-FNA)in the diagnosis of functioning neuroendocrine tumors. Gastrointestinal Endoscopy 56:291-296, 2002
23)Celso Ardengh J, Andrade de Paulo G, Paulo Ferrari A:EUS-guided FNA in the diagnosis of pancreatic neuroendocrine tumors before surgery. Gastrointestinal Endosc 60:378-384, 2004
24)Figueiredo FAF, Giovannini M, Monges G, et al:EUS-FNA predicts 5-year survival in pancreatic endocrine tumors. Gastrointestinal Endosc 70:907-914, 2009
25)Pais SA, Al-Haddad M, Mohamadnejad M, et al:EUS for pancreatic neuroendocrine tumors:a single-center, 11-year experience. Gastrointestinal Endosc 71:1185-1193, 2010
26)Gornals J, Varas M, CataláI, et al:Definitive diagnosis of neuroendocrine tumors using fine-needle aspiration-puncture guided by endoscopic ultrasonography. Rev Esp Enferm Dig 103:123-128, 2011
27)Figueiredo FAF, Giovannini M, Monges G, et al:Pancreatic endocrine tumors:a large single-center experience. Pancreas 38:947, 2009
28)Larghi A, Capurso G, Carnuccio A, et al:Ki-67 grading of nonfunctioning pancreatic neuroendocrine tumors on histologic samples obtained by EUS-guided fine-needle tissue acquisition:a prospective study. Gastrointest Endosc 76:570-577, 2012
29)Hasegawa T, Yamao K, Hijioka S, et al:Evaluation of Ki-67 index in EUS-FNA specimens for the assessment of malignancy risk in pancreatic neuroendocrine tumors. Endoscopy 46:32-38, 2014
30)Farrell JM, Pang JC, Kim GE, et al:Pancreatic neuroendocrine tumors:Accurate grading with Ki-67 index on fine-needle aspiration specimens using the WHO 2010/ENETS criteria. Cancer Cytopathol 122:770-778, 2014
31)Carlinfante G, Baccarini P, Berretti D, et al:Ki-67 cytological index can distinguish well-differentiated from poorly differentiated pancreatic neuroendocrine tumors:a comparative cytohistological study of 53 cases. Virchows Arch 465:49-55, 2014
32)Remes SM, Tuominen VJ, Helin H, et al:Grading of neuroendocrine tumors with Ki-67 requires high-quality assessment practices. Test Site 36:1359-1363, 2012
33)Unno J, Kanno A, Masamune A, et al:The usefulness of endoscopic ultrasound-guided fine-needle aspiration for the diagnosis of pancreatic neuroendocrine tumors based on the World Health Organization classification. Scand J Gastroenterol 49:1367-1374, 2014
34)Aslanian H, Salem RR, Marginean C, et al:EUS-guided ethanol injection of normal porcine pancreas:a pilot study. Gastrointest Endosc 62:723-727, 2005
35)Zhang W-Y, Li Z-S, Jin Z-D:Endoscopic ultrasound-guided ethanol ablation therapy for tumors. World J Gastroenterol 19:3397, 2013
36)Hijioka S, Hosoda W, Mizuno N, et al:Does the WHO 2010 classification of pancreatic neuroendocrine neoplasms accurately characterize pancreatic neuroendocrine carcinomas? J Gastroenterol 2014[Epub ahead of Print]